We develop novel medicines that harness the therapeutic promise of psychedelics to revolutionize the treatment of mental illness
Location: United States, New York
Employees: 11-50
Total raised: $66M
Founded date: 2019
Investors 7
| Date | Name | Website |
| - | JLS Fund | jls.fund |
| 19.01.2022 | Y Combinat... | ycombinato... |
| - | What If Ve... | whatif.vc |
| - | Ambria Cap... | ambriacap.... |
| - | Noetic Fun... | noeticfund... |
| - | Route 66 V... | route66ven... |
| - | Vine Ventu... | vine.vc |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 16.12.2022 | Series B | $39M | - |
| 06.05.2021 | Series A | $27M | - |
Mentions in press and media 7
| Date | Title | Description | Source |
| 27.03.2023 | Here are the 15 hottest startups in the psychedelics industr... | From left: Sherry Rais, a cofounder and the CEO of Enthea; Mark Rus, the CEO of Delix Therapeutics; ... | businessin... |
| 16.12.2022 | Gilgamesh Pharmaceuticals Raises $39M in Series B Funding | Gilgamesh Pharmaceuticals, a New York-based mental health science-focused biotechnology company, rai... | finsmes.co... |
| 15.12.2022 | Gilgamesh Pharmaceuticals Lands $39M Series B | NEW YORK, NY, Gilgamesh Pharmaceuticals today announced the closing of a $39 million Series B roun... | vcnewsdail... |
| 06.05.2021 | Gilgamesh Pharmaceuticals Closes On $27 Million Series A Rou... | NEW YORK, May 6, 2021 /PRNewswire/ -- Gilgamesh Pharmaceuticals, a mental health science focused b... | prnewswire... |
| 06.05.2021 | New York-based biotech startup Gilgamesh Pharmaceuticals rai... | Between 2009 and 2019, spending on mental health care in the United States increased by more than 50... | techstartu... |
| 06.05.2021 | Gilgamesh Pharmaceuticals Snags $27M Series A | NEW YORK, NY, Gilgamesh Pharmaceuticals today announced the closing of a $27 million Series A roun... | vcnewsdail... |
| - | Gilgamesh Pharmaceuticals | “We develop novel medicines that harness the therapeutic promise of psychedelics to revolutionize th... | fastfounde... |